GRP
NKTR icon

Global Retirement Partners’s Nektar Therapeutics NKTR Stock Holding History

Global Retirement Partners’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.14K Hold
27
– – ﹤0.01% 3862
2025
Q3 		$1.54K Hold
27
– – ﹤0.01% 3401
2025
Q2 		$698 Buy
+27
New +$303 ﹤0.01% 3520
2024
Q4 		$387 Buy
28
+27
+2,700% +$476 ﹤0.01% 3441
2024
Q3 		$21 Hold
1
– – ﹤0.01% 3472
2024
Q2 		$20 Hold
1
– – ﹤0.01% 3521
2024
Q1 		$15 Hold
1
– – ﹤0.01% 3364
2023
Q4 		$8 Hold
1
– – ﹤0.01% 3341
2023
Q3 		$8 Hold
1
– – ﹤0.01% 3235
2023
Q2 		$9 Hold
1
– – ﹤0.01% 3181
2023
Q1 		$13 Buy
+1
New +$30 ﹤0.01% 3174
2022
Q3 		– Sell
-6
Closed – – 2881
2022
Q2 		$0 Sell
6
-30
-83% -$1.89K ﹤0.01% 2813
2022
Q1 		$2K Buy
+36
New +$5.33K ﹤0.01% 2217
2021
Q2 		– Sell
-20
Closed -$6K – 1912
2021
Q1 		$6K Hold
20
– – ﹤0.01% 1437
2020
Q4 		$5K Hold
20
– – ﹤0.01% 1450
2020
Q3 		$5K Hold
20
– – ﹤0.01% 1324
2020
Q2 		$7K Buy
+20
New +$6.24K ﹤0.01% 1208
2017
Q3 		– Sell
-11
Closed -$3K – 1235
2017
Q2 		$3K Hold
11
– – ﹤0.01% 1030
2017
Q1 		$4K Hold
11
– – ﹤0.01% 950
2016
Q4 		$2K Buy
+11
New +$2.24K ﹤0.01% 966

Other funds holding NKTR

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Global Retirement Partners's NKTR Position: Q4 2025 in Review

Global Retirement Partners held its Nektar Therapeutics (NKTR) position steady in Q4 2025 at 27 shares worth $1.14K. The position accounts for ﹤0.01% of the portfolio, ranked #3862.

Global Retirement Partners first reported a position in NKTR in Q4 2016 and has held it in 20 quarters since. The position peaked at $7K in Q2 2020. 180 funds tracked by Wall St. Rank hold NKTR as of Q4 2025.

  • Global Retirement Partners held 27 shares of Nektar Therapeutics worth $1.14K as of Q4 2025.
  • Global Retirement Partners left its Nektar Therapeutics share count unchanged in Q4 2025.
  • Nektar Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3862 holding.
  • Global Retirement Partners first reported a position in Nektar Therapeutics in Q4 2016 and has held it in 20 quarters since.
  • Global Retirement Partners's Nektar Therapeutics position peaked at $7K in Q2 2020.
  • 180 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.